Co-Founder, President & COO

Orca Bio Announces FDA Acceptance and Priority Review of the Biologics License Application (BLA) for Orca-T® to Treat Hematological Malignancies

Orca Bio Announces FDA Acceptance and Priority Review of...

Cell therapy startup Orca Bio opens high-tech facility near Sacramento airport

Orca hires ex-Legend exec Gavel to hammer open cell therapy market as CCO

Orca T Account Manager (OTAM)

Orca Bio is a late-stage biotechnology company redefining the transplant process by developing next-generation cell therapies. The Orca T Account Manager (OTAM) will serve as the primary liaison between Orca Bio and Authorized Treatment Centers, responsible for building relationships, supporting clinical site readiness, and driving the use of investigational therapies.

Sign up with Google

Sign in with Google